THOUSAND OAKS, Calif., June 11, 2014 /PRNewswire/ -- Ceres, Inc. (CERE), an agricultural biotechnology and seed company, will evaluate a number of its biotech traits in sugarcane in South America. Plantings were recently completed and preliminary performance observations will be available by the end of the year. Ceres expects to receive sugar yield results in the second half of 2015 when the first growing cycle is completed. Sugarcane provides an additional out-licensing opportunity for traits that the company is developing for its own use in sorghum and other energy crops.
The pilot-scale field evaluations include a number of Ceres' leading traits for high sugar and drought tolerance. According to the company, these first field evaluations in sugarcane are designed to measure the performance of the traits in leading commercial varieties, with a goal of advancing the best plants for broader evaluation. Evaluations will be managed by a South American sugarcane developer.
Roger Pennell, PhD, vice president of trait development for Ceres, said that the company's biotech traits could provide significant benefits to sugarcane production. Higher sugar yields and greater resilience to drought and other stress conditions would not only increase output, but also lower production costs.
"If our greenhouse results are confirmed in the field, plants with Ceres' traits could allow growers to leapfrog ahead of the incremental gains that have been made through plant breeding alone," said Pennell. "Plant breeding is particularly cumbersome in sugarcane. The plants have long growing cycles and common breeding processes are difficult to implement due to limitations in how and when sugarcane plants produce pollen and flowers."
Walter Nelson, Ceres vice president of product development, said that the company intends to work with mills and growers in South America and other sugarcane production areas once it has the field data it needs to determine more definitively the commercial value of these traits in sugarcane. Commercialization timelines will depend primarily on trial results and the regulatory review process in various markets.
"We intend our field evaluations to be a proving ground for a broader rollout of these traits in sugarcane varieties developed for multiple areas," said Nelson.
Ceres has previously out-licensed its genetic technology and genes to other seed companies for use in rice, corn, soybean and sugar beets, among other crops. Ceres is focused on genes that have shown large, clear increases in performance, and whose benefits are maintained across multiple species. The company's field evaluations of its biotech traits in multiple crops have largely confirmed previous results obtained in greenhouse and laboratory settings.
According to the U.N. Food and Agriculture Organization, 62 million acres (25 million hectares) of sugarcane were harvested worldwide in 2012, including 27 million acres (11 million hectares) in South America.
Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand. The company also licenses its technology and biotech traits to other organizations.
CERES FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from our plan to align expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.